HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PEGBIO CO-B

5.935

+0.0500.85%

Volume:3.72M

Turnover:22.03M

Market Cap:2.32B

PE:-9.25

High:6.065

Open:6.040

Low:5.785

Close:5.885

52wk High:77.000

52wk Low:4.940

Shares:391.00M

HK Float Shares:386.00M

Volume Ratio:0.72

T/O Rate:0.96%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.642

ROE:-125.57%

ROA:-46.17%

PB:7.46

PE(LYR):-9.25

PS:-173.75

Loading ...

Overview Company News Filings

PB-2312 Enters the Arena Against Retatrutide and Efruxifermin: What New Card Does PEGBIO Hold?

PegBio interim loss deepens to RMB216 million amid ramp-up in R&D; first HK$61 million royalty marks progress in Paidakang® rollout

Bulletin Express

PEGBIO CO-B Unveils Interim Results with R&D Spending Reaching 110 Million Yuan

Pegbio Co Hy Loss Rmb216.2 Mln

THOMSON REUTERS

PegBio FY26 H1 Net Loss More than Doubles to RMB 216.2 Million

Lexaria Signs Material Transfer Agreement with PegBio to Test DehydraTECH with GLP-1 Molecule

PegBio Schedules 25 August 2026 Board Meeting to Approve 1H26 Interim Results

Bulletin Express

PegBio Schedules Board Meeting to Review Interim Results

Movement Alert｜PEGBIO CO-B Rises 8.82% in Regular Trading, Paidakang Commercialization Triggers Second Milestone Payment of HK$49 Million

Movement Alert｜PEGBIO CO-B Rises 8.93% in Regular Trading, Trading at HK$5.745

PegBio Records Stable Share Capital and Confirms Adequate Public Float for July 2026

Bulletin Express

Movement Alert｜PEGBIO CO-B Declines 8.64% in Regular Trading, Trading at HK$5.4

Movement Alert｜PEGBIO CO-B Falls 8.36% in Regular Trading, Trading at 5.81 HKD

Movement Alert｜PEGBIO CO-B Declines 8.12% in Regular Trading, Trading at 6.36 HKD

PegBio's Diabetes Drug Completes First Batch of Prescriptions

MT Newswires Live

PegBio’s Paidakang® Enters Clinical Use Nationwide, Unlocks HK$49.00 Million Second Royalty from Tenry Pharmaceutical

Bulletin Express

PEGBIO CO-B Announces First Commercial Prescriptions for Paidakang and Fulfillment of Second Milestone Payment

Movement Alert｜PegBio Rises 8.04% in Regular Trading, Three-Party Strategic Cooperation Accelerates Paidakang Commercialization Expectations

PEGBIO CO-B Surges Over 5% on Strategic Collaboration to Accelerate Commercialization of Pai Da Kang

Alibaba Health Inks Strategic Tie-up with Tenry, Pegbio to Launch Glp-1ra Drug

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au.tigermarketb.com/stock/02565/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"02565","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02565\",,,,,undefined,":{"symbol":"02565","market":"HK","secType":"STK","nameCN":"PEGBIO CO-B","latestPrice":5.935,"timestamp":1787810517460,"preClose":5.885,"halted":0,"volume":3720700,"delay":0,"changeRate":0.008496176720475757,"floatShares":386000000,"shares":391000000,"eps":-0.6416379215729315,"marketStatus":"Trading","change":0.05,"latestTime":"08-27 14:02:09","open":6.04,"high":6.065,"low":5.785,"amount":22034588,"amplitude":0.047579,"askPrice":5.955,"askSize":2200,"bidPrice":5.935,"bidSize":450,"shortable":3,"etf":0,"ttmEps":-0.9958127213659669,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787818200000},"marketStatusCode":2,"adr":0,"listingDate":1748275200000,"exchange":"SEHK","adjPreClose":5.885,"openAndCloseTimeList":[[1787794200000,1787803200000],[1787806800000,1787817600000]],"volumeRatio":0.71537,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02565\",,,,,undefined,":{"symbol":"02565","floatShares":386000000,"roa":"-46.17%","roe":"-125.57%","lyrEps":-0.641644,"volumeRatio":0.71537,"shares":391000000,"dividePrice":0,"high":6.065,"amplitude":0.047579,"preClose":5.885,"low":5.785,"week52Low":4.94,"pbRate":"7.46","psRate":"-173.75","week52High":77,"institutionHeld":0,"latestPrice":5.935,"committee":-0.660377,"eps":-0.6416436702311142,"divideRate":0,"volume":3720700,"delay":0,"ttmEps":-0.9958216431998496,"open":6.04,"prevYearClose":69,"prevWeekClose":5.875,"prevMonthClose":5.36,"prevQuarterClose":5.33,"fiveDayClose":5.975,"twentyDayClose":5.45,"sixtyDayClose":8.12},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02565\",params:#limit:5,,,undefined,":[{"date":"2026-08-25","symbol":"02565","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787621400000,"name":null,"time":"","dateTimestamp":1787587200000,"actualEps":null},{"market":"HK","date":"2026-03-23","symbol":"02565","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774195200000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-26","symbol":"02565","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02565\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02565\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02565\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02565","date":"2026-08-26","current":-5.959956,"percent":1,"low":-87.782868,"twenty":-72.82581,"median":-57.71497,"eighty":-11.457087,"high":-5.96603,"avg":-43.945862,"sd":28.144736,"marketCap":2301573665},"quantilePoints":[{"date":"2025-05-30","current":-12.743079,"twenty":-15.470266,"median":-13.542645,"eighty":-13.135794,"marketCap":3936746426},{"date":"2025-06-06","current":-11.987888,"twenty":-13.726785,"median":-12.740515,"eighty":-12.114178,"marketCap":3712892217},{"date":"2025-06-13","current":-11.23576,"twenty":-13.295707,"median":-12.114337,"eighty":-11.528404,"marketCap":3481318898},{"date":"2025-06-20","current":-11.30775,"twenty":-12.841258,"median":-11.963331,"eighty":-11.337793,"marketCap":3496757119},{"date":"2025-06-27","current":-12.421214,"twenty":-12.738977,"median":-11.541778,"eighty":-11.292079,"marketCap":3851836209},{"date":"2025-07-04","current":-13.963875,"twenty":-12.971799,"median":-11.987888,"eighty":-11.299391,"marketCap":4330421069},{"date":"2025-07-11","current":-13.604213,"twenty":-13.050401,"median":-12.199189,"eighty":-11.305737,"marketCap":4214634409},{"date":"2025-07-18","current":-16.956264,"twenty":-13.748078,"median":-12.438987,"eighty":-11.330282,"marketCap":5248995235},{"date":"2025-07-25","current":-19.006677,"twenty":-15.472199,"median":-12.742066,"eighty":-11.352726,"marketCap":5905119639},{"date":"2025-08-01","current":-19.199848,"twenty":-18.276271,"median":-12.906561,"eighty":-11.424474,"marketCap":5928276971},{"date":"2025-08-08","current":-20.51103,"twenty":-19.019895,"median":-13.05938,"eighty":-11.472546,"marketCap":6348968501},{"date":"2025-08-15","current":-39.959751,"twenty":-19.179784,"median":-13.542645,"eighty":-11.515029,"marketCap":12350577024},{"date":"2025-08-22","current":-41.864246,"twenty":-19.284777,"median":-13.964282,"eighty":-11.779976,"marketCap":12898633879},{"date":"2025-08-29","current":-41.44792,"twenty":-21.432837,"median":-14.946806,"eighty":-11.968242,"marketCap":10033166343},{"date":"2025-09-05","current":-50.678037,"twenty":-39.039264,"median":-17.018603,"eighty":-12.06328,"marketCap":12255314482},{"date":"2025-09-12","current":-58.538001,"twenty":-40.749762,"median":-18.438762,"eighty":-12.114019,"marketCap":14181548421},{"date":"2025-09-19","current":-57.311117,"twenty":-43.720929,"median":-18.952908,"eighty":-12.216159,"marketCap":13874467648},{"date":"2025-09-26","current":-63.587749,"twenty":-49.33228,"median":-19.070122,"eighty":-12.366345,"marketCap":15354038645},{"date":"2025-10-03","current":-60.149194,"twenty":-54.575673,"median":-19.16943,"eighty":-12.428323,"marketCap":14558420278},{"date":"2025-10-10","current":-60.121463,"twenty":-57.957283,"median":-19.199848,"eighty":-12.49878,"marketCap":14530503844},{"date":"2025-10-17","current":-60.168303,"twenty":-59.756564,"median":-19.2984,"eighty":-12.738571,"marketCap":14530503844},{"date":"2025-10-24","current":-61.301982,"twenty":-60.143648,"median":-20.51103,"eighty":-12.741458,"marketCap":14809668183},{"date":"2025-10-31","current":-69.345185,"twenty":-60.159469,"median":-22.018639,"eighty":-12.743079,"marketCap":16777776773},{"date":"2025-11-07","current":-59.401661,"twenty":-60.392128,"median":-34.33922,"eighty":-12.780248,"marketCap":14363005241},{"date":"2025-11-14","current":-72.819022,"twenty":-61.035505,"median":-39.959751,"eighty":-12.906561,"marketCap":17657144441},{"date":"2025-11-21","current":-72.852961,"twenty":-61.301982,"median":-40.866122,"eighty":-12.943343,"marketCap":17657144441},{"date":"2025-11-28","current":-82.344376,"twenty":-62.346137,"median":-42.423494,"eighty":-13.014482,"marketCap":20030041323},{"date":"2025-12-05","current":-72.063717,"twenty":-63.355663,"median":-45.122001,"eighty":-13.104279,"marketCap":17559436923},{"date":"2025-12-12","current":-74.217813,"twenty":-64.460997,"median":-48.969529,"eighty":-13.233973,"marketCap":18117765601},{"date":"2025-12-19","current":-71.875632,"twenty":-65.413889,"median":-52.055133,"eighty":-13.542645,"marketCap":17587353357},{"date":"2025-12-24","current":-73.927127,"twenty":-69.382811,"median":-55.337969,"eighty":-13.579586,"marketCap":18145682035},{"date":"2026-01-02","current":-79.895405,"twenty":-70.540926,"median":-57.311117,"eighty":-13.748078,"marketCap":19687798475},{"date":"2026-01-09","current":-85.854057,"twenty":-72.056904,"median":-58.941314,"eighty":-13.964201,"marketCap":21208805289},{"date":"2026-01-16","current":-80.413876,"twenty":-72.839385,"median":-59.401661,"eighty":-14.164153,"marketCap":19929453763},{"date":"2026-01-23","current":-77.735339,"twenty":-73.262106,"median":-59.808211,"eighty":-14.656731,"marketCap":19247132950},{"date":"2026-01-30","current":-73.838267,"twenty":-73.550435,"median":-60.0941,"eighty":-15.472199,"marketCap":18365801899},{"date":"2026-02-06","current":-69.490034,"twenty":-73.32273,"median":-60.154331,"eighty":-16.538679,"marketCap":17328105662},{"date":"2026-02-13","current":-71.473742,"twenty":-73.562339,"median":-60.192909,"eighty":-17.006135,"marketCap":17925136373},{"date":"2026-02-20","current":-71.065981,"twenty":-73.716985,"median":-60.392128,"eighty":-17.056006,"marketCap":17797201221},{"date":"2026-02-27","current":-72.540901,"twenty":-73.438012,"median":-60.796223,"eighty":-17.950543,"marketCap":18365801899},{"date":"2026-03-06","current":-68.036226,"twenty":-73.352041,"median":-61.160082,"eighty":-18.384598,"marketCap":17086450373},{"date":"2026-03-13","current":-60.794114,"twenty":-73.299371,"median":-60.919795,"eighty":-18.597951,"marketCap":15338003289},{"date":"2026-03-20","current":-67.303035,"twenty":-73.275932,"median":-61.206433,"eighty":-18.84686,"marketCap":16915870170},{"date":"2026-03-27","current":-68.867925,"twenty":-73.269478,"median":-61.274827,"eighty":-18.985169,"marketCap":16247764373},{"date":"2026-04-02","current":-85.055535,"twenty":-73.278872,"median":-61.433108,"eighty":-19.026504,"marketCap":20163286400},{"date":"2026-04-10","current":-78.454069,"twenty":-73.369897,"median":-61.662876,"eighty":-19.045802,"marketCap":18741784705},{"date":"2026-04-17","current":-76.94604,"twenty":-73.948705,"median":-62.45145,"eighty":-19.079188,"marketCap":18389252284},{"date":"2026-04-24","current":-60.4786,"twenty":-73.948705,"median":-62.528681,"eighty":-19.126247,"marketCap":14454535592},{"date":"2026-05-15","current":-17.642518,"twenty":-73.927127,"median":-62.346137,"eighty":-19.115451,"marketCap":4376314243},{"date":"2026-05-22","current":-20.448357,"twenty":-73.838267,"median":-61.433108,"eighty":-19.16943,"marketCap":5060724424},{"date":"2026-05-29","current":-13.590249,"twenty":-73.716985,"median":-61.274827,"eighty":-19.064042,"marketCap":3375119921},{"date":"2026-06-05","current":-12.579887,"twenty":-73.438012,"median":-61.206433,"eighty":-18.597951,"marketCap":3128732256},{"date":"2026-06-12","current":-11.565594,"twenty":-73.352041,"median":-60.919795,"eighty":-17.056006,"marketCap":2874522760},{"date":"2026-06-18","current":-9.622776,"twenty":-73.31105,"median":-60.791238,"eighty":-14.753422,"marketCap":2397391091},{"date":"2026-06-26","current":-7.824338,"twenty":-73.278872,"median":-60.512398,"eighty":-13.899973,"marketCap":1939813998},{"date":"2026-07-03","current":-8.984958,"twenty":-73.271235,"median":-60.431019,"eighty":-13.561687,"marketCap":2229221732},{"date":"2026-07-10","current":-11.252888,"twenty":-73.25947,"median":-60.210807,"eighty":-13.050401,"marketCap":2788482623},{"date":"2026-07-17","current":-10.458113,"twenty":-73.235067,"median":-60.159469,"eighty":-12.830773,"marketCap":2600758687},{"date":"2026-07-24","current":-10.046967,"twenty":-73.215248,"median":-60.107782,"eighty":-12.739192,"marketCap":2499074889},{"date":"2026-07-31","current":-8.411523,"twenty":-73.183292,"median":-59.862622,"eighty":-12.522041,"marketCap":2096250611},{"date":"2026-08-07","current":-10.298244,"twenty":-73.061453,"median":-59.675079,"eighty":-12.306772,"marketCap":2571426822},{"date":"2026-08-14","current":-9.745542,"twenty":-72.966779,"median":-59.367669,"eighty":-11.991332,"marketCap":2436500244},{"date":"2026-08-21","current":-9.169953,"twenty":-72.846173,"median":-58.454271,"eighty":-11.546541,"marketCap":2297662750},{"date":"2026-08-26","current":-5.96603,"twenty":-72.82581,"median":-57.71497,"eighty":-11.457087,"marketCap":2301573665}],"updateTime":1787810529908},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02565\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1199128434","title":"PB-2312 Enters the Arena Against Retatrutide and Efruxifermin: What New Card Does PEGBIO Hold?","url":"https://stock-news.laohu8.com/highlight/detail?id=1199128434","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199128434?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:02","pubTimestamp":1787652157,"startTime":"0","endTime":"0","summary":"Viewing PEGBIO CO-B (02565) merely as a company with a single GLP-1 product may no longer be sufficient. The 2026 interim report warrants a fresh look from the capital markets, not for an increased...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64QTZ34.USD","BK1161","BK4211","PB","02565","IE00BLDYK493.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109220815","title":"PegBio interim loss deepens to RMB216 million amid ramp-up in R&D; first HK$61 million royalty marks progress in Paidakang® rollout","url":"https://stock-news.laohu8.com/highlight/detail?id=1109220815","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109220815?lang=en_us&edition=fundamental","pubTime":"2026-08-25 16:48","pubTimestamp":1787647729,"startTime":"0","endTime":"0","summary":"PegBio Co., Ltd. (PegBio) reported a net loss of RMB216.20 million for the six months ended 30 June 2026, more than double the RMB93.67 million loss booked a year earlier. Basic and diluted loss per...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"PegBio interim loss deepens to RMB216 million amid ramp-up in R&D; first HK$61 million royalty marks progress in Paidakang® rollout","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146455709","title":"PEGBIO CO-B Unveils Interim Results with R&D Spending Reaching 110 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1146455709","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146455709?lang=en_us&edition=fundamental","pubTime":"2026-08-25 16:40","pubTimestamp":1787647222,"startTime":"0","endTime":"0","summary":"PEGBIO CO-B (02565) has released its interim financial report for the six months ended June 30, 2025. The company recorded a net loss from other operations of RMB 11.27 million, with research and...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4585","BK1161","399441","161726","02565","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662829577","title":"Pegbio Co Hy Loss Rmb216.2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662829577","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662829577?lang=en_us&edition=fundamental","pubTime":"2026-08-25 16:32","pubTimestamp":1787646754,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nPLX138VLS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02565","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662782985","title":"PegBio FY26 H1 Net Loss More than Doubles to RMB 216.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662782985","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662782985?lang=en_us&edition=fundamental","pubTime":"2026-08-25 16:31","pubTimestamp":1787646712,"startTime":"0","endTime":"0","summary":"PegBio FY26 H1 net loss more than doubles to RMB 216.2 millionPegBio posted an operating loss of RMB 214.23 million for the six months ended June 30, 2026, worsening from RMB 92.14 million.Net loss wi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nNDL9HZ1KZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659157840","title":"Lexaria Signs Material Transfer Agreement with PegBio to Test DehydraTECH with GLP-1 Molecule","url":"https://stock-news.laohu8.com/highlight/detail?id=2659157840","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659157840?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:00","pubTimestamp":1786626053,"startTime":"0","endTime":"0","summary":"Lexaria signs material transfer agreement with PegBio to test DehydraTECH with GLP-1 moleculeLexaria entered a material transfer agreement with PegBio to test DehydraTECH with PegBio’s proprietary GLP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL5fBfXZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02565","LEXX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141430077","title":"PegBio Schedules 25 August 2026 Board Meeting to Approve 1H26 Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1141430077","media":"Bulletin Express","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141430077?lang=en_us&edition=fundamental","pubTime":"2026-08-13 17:09","pubTimestamp":1786612170,"startTime":"0","endTime":"0","summary":"PegBio Co., Ltd. announced that its board of directors will convene on 25 August 2026 to review and approve the Group’s interim financial results for the six months ended 30 June 2026. The meeting...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659137998","title":"PegBio Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659137998","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659137998?lang=en_us&edition=fundamental","pubTime":"2026-08-13 16:58","pubTimestamp":1786611536,"startTime":"0","endTime":"0","summary":"PegBio schedules board meeting to review interim resultsPegBio will hold a board meeting on Aug. 25, 2026.The board is set to review interim results for the six months ended June 30, 2026.Disclaimer:T","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL6k16WS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105232336","title":"Movement Alert｜PEGBIO CO-B Rises 8.82% in Regular Trading, Paidakang Commercialization Triggers Second Milestone Payment of HK$49 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1105232336","media":"Market Focus","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105232336?lang=en_us&edition=fundamental","pubTime":"2026-08-13 10:54","pubTimestamp":1786589673,"startTime":"0","endTime":"0","summary":"On August 13, PEGBIO CO-B rose 8.82% in regular trading, reaching HK$6.725, with turnover of approximately HK$90.85 million. The rally was driven by continued commercialization momentum of the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110969594","title":"Movement Alert｜PEGBIO CO-B Rises 8.93% in Regular Trading, Trading at HK$5.745","url":"https://stock-news.laohu8.com/highlight/detail?id=1110969594","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110969594?lang=en_us&edition=fundamental","pubTime":"2026-08-07 14:53","pubTimestamp":1786085593,"startTime":"0","endTime":"0","summary":"On August 7, PEGBIO CO-B rose 8.93% in regular trading, trading at HK$5.745/share, with turnover of HK$45.43 million.Within the Biotechnology sector where PEGBIO CO-B belongs, the sector showed...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143828487","title":"PegBio Records Stable Share Capital and Confirms Adequate Public Float for July 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1143828487","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143828487?lang=en_us&edition=fundamental","pubTime":"2026-08-05 17:25","pubTimestamp":1785921915,"startTime":"0","endTime":"0","summary":"For the month ended 31 July 2026, PegBio Co., Ltd. reported no changes in its registered or issued share capital, according to the company’s monthly return submitted on 05 August 2026 to Hong Kong...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123282253","title":"Movement Alert｜PEGBIO CO-B Declines 8.64% in Regular Trading, Trading at HK$5.4","url":"https://stock-news.laohu8.com/highlight/detail?id=1123282253","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123282253?lang=en_us&edition=fundamental","pubTime":"2026-07-30 15:21","pubTimestamp":1785396078,"startTime":"0","endTime":"0","summary":"On July 30, PEGBIO CO-B declined 8.64% in regular trading, trading at HK$5.4/share, with turnover of HK$27.86 million.Within the Biotechnology sector where PEGBIO CO-B belongs, the sector exhibited...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159229678","title":"Movement Alert｜PEGBIO CO-B Falls 8.36% in Regular Trading, Trading at 5.81 HKD","url":"https://stock-news.laohu8.com/highlight/detail?id=1159229678","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159229678?lang=en_us&edition=fundamental","pubTime":"2026-07-28 14:09","pubTimestamp":1785218942,"startTime":"0","endTime":"0","summary":"On July 28, PEGBIO CO-B fell 8.36% in regular trading, trading at 5.81 HKD/share, with Turnover of HKD 36.11 million.Within the Biotechnology sector where PEGBIO CO-B belongs, the sector showed broad...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198005740","title":"Movement Alert｜PEGBIO CO-B Declines 8.12% in Regular Trading, Trading at 6.36 HKD","url":"https://stock-news.laohu8.com/highlight/detail?id=1198005740","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198005740?lang=en_us&edition=fundamental","pubTime":"2026-07-24 14:01","pubTimestamp":1784872872,"startTime":"0","endTime":"0","summary":"On July 24, PEGBIO CO-B declined 8.12% in regular trading, trading at 6.36 HKD/share, with turnover of HK$44.80 million.Within the Biotechnology sector where PEGBIO CO-B belongs, the sector showed...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653763372","title":"PegBio's Diabetes Drug Completes First Batch of Prescriptions","url":"https://stock-news.laohu8.com/highlight/detail?id=2653763372","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653763372?lang=en_us&edition=fundamental","pubTime":"2026-07-22 21:14","pubTimestamp":1784726047,"startTime":"0","endTime":"0","summary":"PegBio  said the first batch of commercial prescriptions of Paidakang has been issued at multiple medical institutions, according to a Wednesday Hong Kong bourse filing.Ji Linong and Zhou Zhiguang issued the first respective prescriptions at Peking University People's Hospital and Second Xiangya Hospital of Central South University.Ji and Zhou were the leading experts of a phase III clinical study of Paidakang, which is used for the treatment of type 2 diabetes in adults.Following the prescriptions, Tenry Pharmaceutical, which had entered into a commercialization collaboration agreement with the company, is due to satisfy a second royalty payment.Tenry Pharmaceutical has confirmed it will pay around HK$49 million in royalty to the biopharmaceutical company under the contract.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02565","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193880564","title":"PegBio’s Paidakang® Enters Clinical Use Nationwide, Unlocks HK$49.00 Million Second Royalty from Tenry Pharmaceutical","url":"https://stock-news.laohu8.com/highlight/detail?id=1193880564","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193880564?lang=en_us&edition=fundamental","pubTime":"2026-07-22 18:21","pubTimestamp":1784715690,"startTime":"0","endTime":"0","summary":"PegBio Co., Ltd. (PegBio) announced that, as of 22 July 2026, the first batch of commercial prescriptions for Paidakang®—its once-weekly glucagon-like peptide-1 receptor agonist (GLP-1RA) for adult...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182451049","title":"PEGBIO CO-B Announces First Commercial Prescriptions for Paidakang and Fulfillment of Second Milestone Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=1182451049","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182451049?lang=en_us&edition=fundamental","pubTime":"2026-07-22 18:10","pubTimestamp":1784715039,"startTime":"0","endTime":"0","summary":"PEGBIO CO-B (ASX: 02565) has announced that, as of July 22, 2026, the first commercial prescriptions for Paidakang® have been issued across multiple medical institutions in China, including Peking...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["161726","BK4588","XBI","BK1161","02565","BK4581","BK4585","399441"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193644409","title":"Movement Alert｜PegBio Rises 8.04% in Regular Trading, Three-Party Strategic Cooperation Accelerates Paidakang Commercialization Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=1193644409","media":"Market Focus","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193644409?lang=en_us&edition=fundamental","pubTime":"2026-07-21 14:59","pubTimestamp":1784617161,"startTime":"0","endTime":"0","summary":"On July 21, PegBio (02565.HK) rose 8.04% in regular trading, reaching HK$7.39, with turnover of HK$148 million.On the news front, on July 17, PegBio, Shanghai Tenry Pharmaceutical, and Ali Health...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149654436","title":"PEGBIO CO-B Surges Over 5% on Strategic Collaboration to Accelerate Commercialization of Pai Da Kang","url":"https://stock-news.laohu8.com/highlight/detail?id=1149654436","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149654436?lang=en_us&edition=fundamental","pubTime":"2026-07-20 11:54","pubTimestamp":1784519664,"startTime":"0","endTime":"0","summary":"Shares of PEGBIO CO-B (02565) rose more than 5%. At the time of writing, the stock was up 5.41% to HK$7.01, with a turnover of HK$132 million.On the news front, on July 17, PEGBIO CO-B, Shanghai...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565","161726","VXUS","KCAI","BK4588","BK4585","XBI","399441","BK1161","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652628894","title":"Alibaba Health Inks Strategic Tie-up with Tenry, Pegbio to Launch Glp-1ra Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2652628894","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652628894?lang=en_us&edition=fundamental","pubTime":"2026-07-17 19:57","pubTimestamp":1784289464,"startTime":"0","endTime":"0","summary":"BRIEF-Alibaba Health Inks Strategic Tie-Up With Tenry, PegBio To Launch GLP-1RA DrugJuly 17 (Reuters)-Alibaba Health Information Technology Ltd0241.HK:SAYS IT SIGNED STRATEGIC COOPERATION WITH TENRY PHARMACEUTICAL AND PEGBIO CO LTD TO LAUNCH GLP-1RA DRUGSource textFurther company coverage:0241.HK","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nL4N43J0WI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1142","02565","BK1502","BK1571","HK0000165453.HKD","BK1589","BK1615","BK1515","BK1247","BK1617","BK1584","BK1161","BK1591","BK1501","BK1189","00241","BK1610"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":120,"code":"91000000","status":"200"}]}}